Specific Topics of Lobbying Communications |
Intended Outcomes |
Associated Subject Matters |
Continued support for Ministry of Health's policies regarding switching patients to biosimilar medicines from biologics
|
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Expansion of reimbursement criteria by the Government of British Columbia for biosimilar products.
|
-
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
|